Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
18.4M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
930K
-
Shares change
-
+930K
-
Total reported value, excl. options
-
$2.15M
-
Value change
-
+$2.15M
-
Number of buys
-
18
-
Price
-
$2.32
Significant Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) as of Q1 2023
19 filings reported holding CASI - CASI Pharmaceuticals, Inc. - Ordinary Shares as of Q1 2023.
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 930K shares
of 18.4M outstanding shares and own 5.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (258K shares), Wellington Shields Capital Management, LLC (180K shares), Wellington Shields & Co., LLC (139K shares), GEODE CAPITAL MANAGEMENT, LLC (98.1K shares), BlackRock Inc. (91.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38.3K shares), STATE STREET CORP (35.6K shares), NORTHERN TRUST CORP (29.8K shares), FRANKLIN RESOURCES INC (24.9K shares), and RENAISSANCE TECHNOLOGIES LLC (13.1K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.